Carboplatin
Contents
Description
Carboplatin is a second-generation platinum compound chemotherapy agent with a mechanism similar to cisplatin but with reduced nephrotoxicity and neurotoxicity. It is used in treatment protocols for rare thoracic malignancies including pulmonary blastoma, often in combination with other chemotherapeutic agents. The drug has orphan designation for several rare cancers.
Indications & Therapeutic Use
Ovarian cancer, lung cancer, pulmonary blastoma, germ cell tumors
Linked Diseases:
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Carboplatin — GNH India
175 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Carboplatin |
| Brands | 1 brand available |
| Active Ingredient | Carboplatin |
| Drug Class | Ovarian cancer |
| Manufacturer | Bristol-Myers Squibb |
| Dosage Forms | IV infusion 10mg/mL |
| Medical Code | L01XA02 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |